<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="163236">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02051296</url>
  </required_header>
  <id_info>
    <org_study_id>RX000487</org_study_id>
    <nct_id>NCT02051296</nct_id>
  </id_info>
  <brief_title>Minocycline to Reduce Pain After Carpal Tunnel Release</brief_title>
  <official_title>A Trial of Minocycline for Pain After Carpal Tunnel and Trigger Release</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Palo Alto Health Care System</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Palo Alto Health Care System</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are looking at whether peri-operative minocycline will reduce the duration
      of pain after minor hand surgery: carpal tunnel release and trigger finger release.

      The investigators' hypothesis is that minocycline will reduce post-operative pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a double blinded randomized controlled trial.  Patients are given 100mg of
      minocycline 2 hours prior to their procedure and then 100mg  two times a day for 5 days.
      The subjects are then contacted daily to check their level of pain.  The investigators'
      outcome of interest is time to pain resolution.

      The investigators will perform a futility analysis to assess if a larger trial would be a
      reasonable next step after this pilot study.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2012</start_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>time to pain resolution</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>the time until patient answers no pain at surgical site for three consecutive days</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Chronic Pain</condition>
  <condition>Post-operative Pain</condition>
  <arm_group>
    <arm_group_label>minocycline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>perioperative minocycline for 5 days, starting 2 hours prior to surgery then 100mg BID</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>PLacebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Minocycline</intervention_name>
    <description>RCT blinded placebo trial</description>
    <arm_group_label>minocycline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult, Veteran,

        Exclusion Criteria:

          -  Kidney failure, Liver failure, thrombocytopenia, ALS, SLE, Frailty, unable to
             understand survery
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catherine Curtin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Palo Alto Veterans Hsopital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Palo Alto VA</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 19, 2014</lastchanged_date>
  <firstreceived_date>January 26, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>VA Palo Alto Health Care System</investigator_affiliation>
    <investigator_full_name>Catherine Curtin</investigator_full_name>
    <investigator_title>Staff Physician</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Carpal Tunnel Syndrome</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Minocycline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
